Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21751366 | 0.85 | ENPP2 (0.38) | ALOX5APFEN1 | |
| SCHEMBL15912872 | 0.79 | ALOX5AP (0.38) | ALOX5APFEN1 | |
| SCHEMBL29950952 | 0.76 | ALOX5AP (0.36) | ALOX5APFEN1 | |
| SCHEMBL15912887 | 0.76 | FEN1 (0.54) | ALOX5APFEN1 | |
| SCHEMBL23537729 | 0.76 | ALOX5AP (0.40) | ALOX5APFEN1DRD2 | |
| SCHEMBL2555302 | 0.75 | DRD2 (0.33) | ALOX5APFEN1DRD2 | |
| SCHEMBL5981875 | 0.75 | ALOX5AP (0.31) | ALOX5APFEN1 | |
| SCHEMBL15269311 | 0.74 | ENPP2 (0.52) | DRD2 | |
| SCHEMBL8162621 | 0.74 | ALOX5AP (0.35) | ALOX5APFEN1 | |
| SCHEMBL29470875 | 0.72 | ENPP2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2065361-B1 | Polymerisable compounds | MERCK PATENT GMBH (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-7807068-B2 | reacting 4-halo-2,6-difluorophenol with protecting group, dehalogenating to form protected phenol ether group, reacting with boronic acid/ester, coupling in presence of catalyst, deblocking, etherifying, esterifying; for optical, electro-optical and electronic use, liquid-crystal media and displays | MERCK PATENT GESELLSCHAFT (DE) | 2010-10-05 | — | — | US | disclosed |
| US-20090141215-A1 | POLYMERIZABLE COMPOUNDS | MERCK PATENT GESELLSCHAFT (DE) | 2009-06-04 | — | — | US | disclosed |
| EP-2065361-A2 | Polymerisable compounds | Merck Patent GmbH (DE) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090141215-A1 | POLYMERIZABLE COMPOUNDS | VCL, LCP1, LPXN | ALOX5AP 1543/4885FEN1 3872/4885DRD2 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.